A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).

Clinical trial NCT05354596 · RECRUITING

Trial details

NCT number: NCT05354596
Sponsor: Rigshospitalet, Denmark
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer Metastases to Lung Radiotherapy Side Effect

Start date: 2022-11-01
Primary completion: 2025-12-30
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.